Hobeika C, Cauchy F, Weiss E, Chopinet S, Sepulveda A, Dondero F, Khoy-Ear L, Grigoresco B, Dokmak S, Durand F, Le Roy B, Paugam-Burtz C, Soubrane O
Department of Hepato-Pancreato-Biliary Surgery and Liver Transplantation, Beaujon Hospital, Assistance Publique-Hôpitaux de Paris and Université de Paris, Clichy, France.
Department of Anaesthesiology and Critical Care, Beaujon Hospital, Assistance Publique-Hôpitaux de Paris and Université de Paris, Clichy, France.
BJS Open. 2021 Jan 8;5(1). doi: 10.1093/bjsopen/zraa031.
This study aimed to identify a subgroup of recipients at low risk of haemorrhage, bile leakage and ascites following liver transplantation (LT).
Factors associated with significant postoperative ascites (more than 10 ml/kg on postoperative day 5), bile leakage and haemorrhage after LT were identified using three separate multivariable analyses in patients who had LT in 2010-2019. A model predicting the absence of all three outcomes was created and validated internally using bootstrap procedure.
Overall, 944 recipients underwent LT. Rates of ascites, bile leakage and haemorrhage were 34.9, 7.7 and 6.0 per cent respectively. The 90-day mortality rate was 7.0 per cent. Partial liver graft (relative risk (RR) 1.31; P = 0.021), intraoperative ascites (more than 10 ml/kg suctioned after laparotomy) (RR 2.05; P = 0.001), malnutrition (RR 1.27; P = 0.006), portal vein thrombosis (RR 1.56; P = 0.024) and intraoperative blood loss greater than 1000 ml (RR 1.39; P = 0.003) were independently associated with postoperative ascites and/or bile leak and/or haemorrhage, and were introduced in the model. The model was well calibrated and predicted the absence of all three outcomes with an area under the curve of 0.76 (P = 0.001). Of the 944 patients, 218 (23.1 per cent) fulfilled the five criteria of the model, and 9.6 per cent experienced postoperative ascites (RR 0.22; P = 0.001), 1.8 per cent haemorrhage (RR 0.21; P = 0.033), 4.1 per cent bile leak (RR 0.54; P = 0.048), 40.4 per cent severe complications (RR 0.70; P = 0.001) and 1.4 per cent 90-day mortality (RR 0.13; P = 0.004).
A practical model has been provided to identify patients at low risk of ascites, bile leakage and haemorrhage after LT; these patients could potentially qualify for inclusion in non-abdominal drainage protocols.
本研究旨在确定肝移植(LT)后出血、胆漏和腹水风险较低的受者亚组。
在2010 - 2019年接受LT的患者中,通过三项独立的多变量分析确定与LT术后大量腹水(术后第5天超过10 ml/kg)、胆漏和出血相关的因素。创建了一个预测所有三种结局均不存在的模型,并使用自举程序进行内部验证。
总体而言,944例受者接受了LT。腹水、胆漏和出血的发生率分别为34.9%、7.7%和6.0%。90天死亡率为7.0%。部分肝移植(相对风险(RR)1.31;P = 0.021)、术中腹水(剖腹术后吸出超过10 ml/kg)(RR 2.05;P = 0.001)、营养不良(RR 1.27;P = 0.006)、门静脉血栓形成(RR 1.56;P = 0.024)和术中失血超过1000 ml(RR 1.39;P = 0.003)与术后腹水和/或胆漏和/或出血独立相关,并被纳入模型。该模型校准良好,预测所有三种结局均不存在的曲线下面积为0.76(P = 0.001)。在944例患者中,218例(23.1%)符合模型的五项标准,9.6%发生术后腹水(RR 0.22;P = 0.001),1.8%发生出血(RR 0.21;P = 0.033),4.1%发生胆漏(RR 0.54;P = 0.048),40.4%发生严重并发症(RR 0.70;P = 0.001),1.4%在90天内死亡(RR 0.13;P = 0.004)。
提供了一个实用模型,以识别LT后腹水、胆漏和出血风险较低的患者;这些患者可能有资格纳入非腹腔引流方案。